Metronidazole USP from Japan
Metronidazole is a nitroimidazole derivative used as an antibiotic and antiprotozoal agent for treating infections like bacterial vaginosis and trichomoniasis. It features an unfused imidazole ring in its aromatic structure, classifying it under HTS 2933.29.35.00 as a nitrogen-heterocyclic compound described in additional U.S. note 3 to section VI.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.628.5%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Provide Certificate of Analysis (CoA) and pharmacopeial compliance documentation to verify USP grade and purity standards
• Ensure DMF (Drug Master File) registration with FDA if intended for pharmaceutical manufacturing
• Avoid misclassification as finished dosage forms which fall under Chapter 30